[Inherited platelet disorders : clinical presentations and diagnostic algorithms]
Revue Medicale De Liege
|December 14, 2019
Summary
Diagnosing rare inherited platelet disorders (IPDs) is challenging due to their varied symptoms and need for specialized tests. Early diagnosis is crucial to prevent harmful treatments and guide appropriate patient care.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Background:
- Inherited platelet disorders (IPDs) are rare conditions with a broad clinical spectrum.
- Late diagnosis of IPDs can result from their rarity and the need for specialized assays.
- Early diagnosis is vital to prevent unnecessary and potentially harmful treatments.
Purpose of the Study:
- To describe the diagnostic challenges of inherited platelet disorders.
- To outline diagnostic algorithms for well-known IPDs.
- To emphasize the importance of early IPD diagnosis.
Main Methods:
- Review of clinical presentation and diagnostic workup for IPDs.
- Description of specialized biological assays.
- Presentation of diagnostic algorithms for common IPDs.
Main Results:
- IPDs present with a wide range of hemorrhagic symptoms.
- Specialized biological assays are essential for definitive diagnosis.
- A systematic approach including history, physical exam, and initial lab tests can raise suspicion for IPD.
Conclusions:
- Early diagnosis of IPDs is critical for effective patient management.
- Referral to specialists is necessary for comprehensive diagnostic workup.
- Understanding diagnostic algorithms aids in timely and accurate identification of IPDs.
More Related Videos
Related Concept Videos
Formation of the Platelet Plug
8.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.5K
Structure and Function of Platelets
2.7K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
996
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
996


